These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 23300932)

  • 41. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
    Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
    Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia.
    Claiborne DT; Dudek TE; Maldini CR; Power KA; Ghebremichael M; Seung E; Mellors EF; Vrbanac VD; Krupp K; Bisesi A; Tager AM; Knipe DM; Boutwell CL; Allen TM
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
    Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
    J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
    Anderson JS; Javien J; Nolta JA; Bauer G
    Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice.
    Long BR; Stoddart CA
    J Virol; 2012 Mar; 86(6):3327-36. PubMed ID: 22238321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
    Yu J; Liu SL
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rγnull mice allows HIV replication and development of anti-HIV immune responses.
    Singh M; Singh P; Gaudray G; Musumeci L; Thielen C; Vaira D; Vandergeeten C; Delacroix L; Van Gulck E; Vanham G; de Leval L; Rahmouni S; Moutschen M
    PLoS One; 2012; 7(6):e38491. PubMed ID: 22675567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.
    Anderson J; Akkina R
    AIDS Res Ther; 2005 Jan; 2(1):1. PubMed ID: 15813990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection.
    Herrera-Carrillo E; Berkhout B
    PLoS One; 2017; 12(5):e0177935. PubMed ID: 28542329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of CD4, CXCR-4, and CCR-5 makes human hematopoietic progenitor cell lines infected with human herpesvirus-6 susceptible to human immunodeficiency virus type 1.
    Vignoli M; Furlini G; Re MC; Ramazzotti E; La Placa M
    J Hematother Stem Cell Res; 2000 Feb; 9(1):39-45. PubMed ID: 10738970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
    Glushakova S; Yi Y; Grivel JC; Singh A; Schols D; De Clercq E; Collman RG; Margolis L
    J Clin Invest; 1999 Sep; 104(5):R7-R11. PubMed ID: 10487781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice.
    Hur EM; Patel SN; Shimizu S; Rao DS; Gnanapragasam PN; An DS; Yang L; Baltimore D
    Blood; 2012 Nov; 120(23):4571-82. PubMed ID: 23065154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of CXCR4-tropic HIV-1 infection by lipopolysaccharide: evidence of different mechanisms in macrophages and T lymphocytes.
    Verani A; Sironi F; Siccardi AG; Lusso P; Vercelli D
    J Immunol; 2002 Jun; 168(12):6388-95. PubMed ID: 12055257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.
    Watanabe S; Terashima K; Ohta S; Horibata S; Yajima M; Shiozawa Y; Dewan MZ; Yu Z; Ito M; Morio T; Shimizu N; Honda M; Yamamoto N
    Blood; 2007 Jan; 109(1):212-8. PubMed ID: 16954502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
    Matsuda S; Miyata M
    Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
    Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
    J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition.
    Guo Q; Zhang J; Parikh K; Brinkley A; Lin S; Zakarian C; Pernet O; Shimizu S; Khamaikawin W; Hacke K; Kasahara N; An DS
    Mol Ther; 2024 Feb; 32(2):384-394. PubMed ID: 38087779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
    Lai Y
    Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.
    Kambal A; Mitchell G; Cary W; Gruenloh W; Jung Y; Kalomoiris S; Nacey C; McGee J; Lindsey M; Fury B; Bauer G; Nolta JA; Anderson JS
    Mol Ther; 2011 Mar; 19(3):584-93. PubMed ID: 21119622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of an HIV resistant T-cell line by targeted "stacking" of restriction factors.
    Voit RA; McMahon MA; Sawyer SL; Porteus MH
    Mol Ther; 2013 Apr; 21(4):786-95. PubMed ID: 23358186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.